Gedeon Richter

Silver Sponsor - Booth 6

Description

Richter aspires to be a global innovator in some key scientific fields, while dedicated to making medicines more accessible worldwide. Founded in 1901, headquartered in Hungary, it operates Central Europe’s largest R&D hub. Its research drives breakthroughs in Neuropsychiatry and Women’s Healthcare, while Biotechnology and General Medicines strengthen its affordable treatment portfolio. One of our latest achievements is the original antipsychotic, cariprazine, marketed in the US for bipolar disorder, schizophrenia and adjunctive treatment of major depressive disorder and in most of the European countries, many MENA countries, Australia, South-Africa and some Asian countries for treatment of schizophrenia in adult patients.